MedTrace Logo

BOND Study: the Benefit Of Night Splinting in Dupuytrens'

NCT03031080 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2021-09-27

No results posted yet for this study

Summary

The BOND study is a prospective, randomised single blinded controlled trial to assess the effect of night splinting in patients who have had collagenase injection and manipulation therapy for Dupuytren's Contracture.

Conditions

  • Dupuytren Contracture

Interventions

DEVICE

Thermoplastic Hand Splint

Thermoplastic Night splint created and moulded to the individual patients hand in-house using generic thermoplastic.

Sponsors & Collaborators

  • Liverpool University Hospitals NHS Foundation Trust

    lead OTHER_GOV

Principal Investigators

  • Graham Cheung, MBBCh FRCS · Consultant Hand Surgeon

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2018-12-31
Completion
2019-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03031080 on ClinicalTrials.gov